Anaplastic Oligodendroglioma (AO) Completed Phase 2 Trials for Trametinib (DB08911)

Also known as: Anaplastic Oligodendroglioma / Anaplastic Oligodendrogliomas / Malignant oligodendroglioma / Oligodendroglioma, anaplastic (morphologic abnormality) / Oligodendroglioma malignant

DBCOND0052374 (Anaplastic Oligodendroglioma (AO))Completed2 IdentifierTitlePurposeDrugs
NCT02684058Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG TumorsTreatment